Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Article in The Lancet Haematology (May 2021)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in The Lancet Haematology (May 2021)
Book chapter (April 2021)
Article in Frontiers in Physiology (May 2020)